Dr. Bénard has more than 20 years of experience in radiopharmaceutical development and has published more than 200 papers in the field. Dr. Bénard is currently the BC Leadership Chair in Functional Cancer Imaging, based at the University of British Columbia (UBC), and Professor in the department of Radiology. Dr. Bénard is also a Distinguished Scientist at BC Cancer, and a recipient of the 2015 NSERC Brockhouse Canada Prize for Interdisciplinary Research in Science and Engineering. His research focuses on the development of novel radiopharmaceuticals for cancer diagnosis and therapy, their translation towards clinical implementation, and designing/conducting clinical trials in nuclear medicine.
Dr. Bénard trained in nuclear medicine in Sherbrooke, Canada, where he became head of the Molecular Imaging Center at the Centre Hospitalier Universitaire de Sherbrooke, and Professor of nuclear medicine and radiobiology at the Université de Sherbrooke. He completed his early training at the University of Pennsylvania under Abass Alavi, whose team performed the first whole body FDG PET scan.